Literature DB >> 18070961

Clinical and economic impact of common multidrug-resistant gram-negative bacilli.

Christian G Giske1, Dominique L Monnet, Otto Cars, Yehuda Carmeli.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18070961      PMCID： PMC2258516          DOI： 10.1128/AAC.01169-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  85 in total

1.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Authors: 
Journal:  Am J Infect Control       Date:  2004-12       Impact factor: 2.918

Review 2.  Tigecycline: what is it, and where should it be used?

Authors:  David M Livermore
Journal:  J Antimicrob Chemother       Date:  2005-08-24       Impact factor: 5.790

3.  Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.

Authors:  James A Karlowsky; Mark E Jones; Clyde Thornsberry; Alan T Evangelista; Y Cheung Yee; Daniel F Sahm
Journal:  Clin Infect Dis       Date:  2005-02-15       Impact factor: 9.079

4.  Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.

Authors:  Kevin B Laupland; Michael D Parkins; Deirdre L Church; Daniel B Gregson; Thomas J Louie; John M Conly; Sameer Elsayed; Johann D D Pitout
Journal:  J Infect Dis       Date:  2005-09-26       Impact factor: 5.226

5.  Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center.

Authors:  C L Emery; L A Weymouth
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).

Authors:  Yoichi Hirakata; Junichi Matsuda; Yoshitsugu Miyazaki; Shimeru Kamihira; Sayoko Kawakami; Yukihisa Miyazawa; Yasuo Ono; Nobuhiko Nakazaki; Yasuyoshi Hirata; Matsuhisa Inoue; John D Turnidge; Jan M Bell; Ronald N Jones; Shigeru Kohno
Journal:  Diagn Microbiol Infect Dis       Date:  2005-08       Impact factor: 2.803

Review 7.  The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!

Authors:  Jodi M Thomson; Robert A Bonomo
Journal:  Curr Opin Microbiol       Date:  2005-10       Impact factor: 7.934

Review 8.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

9.  Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.

Authors:  Cheol-In Kang; Sung-Han Kim; Dong Min Kim; Wan Beom Park; Ki-Deok Lee; Hong-Bin Kim; Myoung-Don Oh; Eui-Chong Kim; Kang-Won Choe
Journal:  Infect Control Hosp Epidemiol       Date:  2004-10       Impact factor: 3.254

10.  Endemic multidrug-resistant Pseudomonas aeruginosa in critically ill patients.

Authors:  Bryan Ortega; A B Johan Groeneveld; Constance Schultsz
Journal:  Infect Control Hosp Epidemiol       Date:  2004-10       Impact factor: 3.254
View more
  184 in total

1.  Polymyxin use associated with respiratory arrest.

Authors:  Hannah Wunsch; Vivek K Moitra; Mona Patel; Amy L Dzierba
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies.

Authors:  Enrico Maria Trecarichi; Mario Tumbarello; Morena Caira; Anna Candoni; Chiara Cattaneo; Domenico Pastore; Rosa Fanci; Annamaria Nosari; Nicola Vianelli; Alessandro Busca; Antonio Spadea; Livio Pagano
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

3.  In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods.

Authors:  Thean Yen Tan; Tze Peng Lim; Winnie Hui Ling Lee; Suranthran Sasikala; Li Yang Hsu; Andrea Lay-Hoon Kwa
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

4.  A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria.

Authors:  Luigi Segagni Lusignani; Alexander Blacky; Peter Starzengruber; Magda Diab-Elschahawi; Thomas Wrba; Elisabeth Presterl
Journal:  Wien Klin Wochenschr       Date:  2016-01-27       Impact factor: 1.704

Review 5.  Development of novel antibacterial drugs to combat multiple resistant organisms.

Authors:  Matteo Bassetti; Elda Righi
Journal:  Langenbecks Arch Surg       Date:  2015-02-11       Impact factor: 3.445

6.  Prior colonization is associated with increased risk of antibiotic-resistant Gram-negative bacteremia in cancer patients.

Authors:  Aaron S Hess; Michael Kleinberg; John D Sorkin; Giora Netzer; Jennifer K Johnson; Michelle Shardell; Kerri A Thom; Anthony D Harris; Mary-Claire Roghmann
Journal:  Diagn Microbiol Infect Dis       Date:  2014-01-30       Impact factor: 2.803

7.  Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016.

Authors:  Sibylle H Lob; Meredith A Hackel; Daryl J Hoban; Katherine Young; Mary R Motyl; Daniel F Sahm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-12       Impact factor: 3.267

8.  α-Tocopherol Attenuates the Severity of Pseudomonas aeruginosa-induced Pneumonia.

Authors:  Brant M Wagener; Naseem Anjum; Cilina Evans; Angela Brandon; Jaideep Honavar; Judy Creighton; Maret G Traber; Robert L Stuart; Troy Stevens; Jean-Francois Pittet
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

9.  Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.

Authors:  Kevin P Connors; Seth T Housman; J Samuel Pope; John Russomanno; Edward Salerno; Eric Shore; Susan Redican; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

Review 10.  Newer antibacterial drugs for a new century.

Authors:  Gina Devasahayam; William M Scheld; Paul S Hoffman
Journal:  Expert Opin Investig Drugs       Date:  2010-02       Impact factor: 6.206
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.